{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15"],"submitter":["Bayas A"],"pubmed_abstract":["<h4>Background</h4>Symptomatic and asymptomatic delayed non-ischemic cerebral enhancing (NICE) lesions in magnetic resonance imaging (MRI) have been reported as a rare complication after endovascular therapy (EVT) in recent years with incidence rates between 0.05% and 0.9% in most studies. Information on long-term clinical course and immunotherapies is scarce or has not been reported in detail in the literature. Objective: Aims of our study were to assess the incidence of NICE lesions in patients after cerebral EVT over a period of more than 12 years, describe clinical and EVT characteristics, and immunotherapies applied.<h4>Methods</h4>A retrospective chart review of all patients treated by endovascular therapy for symptomatic or asymptomatic aneurysms at the University Hospital of Augsbu"],"journal":["Therapeutic advances in neurological disorders"],"pagination":["17562864211072372"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8808010"],"repository":["biostudies-literature"],"pubmed_title":["Incidence, clinical spectrum, and immunotherapy of non-ischemic cerebral enhancing lesions after endovascular therapy."],"pmcid":["PMC8808010"],"pubmed_authors":["Welzel J","Muller M","Bayas A","Maurer C","Christ M","Berlis A","Ann Gerdes L","Ertl M","Naumann M","Seelos K","Joachimski F"],"additional_accession":[]},"is_claimable":false,"name":"Incidence, clinical spectrum, and immunotherapy of non-ischemic cerebral enhancing lesions after endovascular therapy.","description":"<h4>Background</h4>Symptomatic and asymptomatic delayed non-ischemic cerebral enhancing (NICE) lesions in magnetic resonance imaging (MRI) have been reported as a rare complication after endovascular therapy (EVT) in recent years with incidence rates between 0.05% and 0.9% in most studies. Information on long-term clinical course and immunotherapies is scarce or has not been reported in detail in the literature. Objective: Aims of our study were to assess the incidence of NICE lesions in patients after cerebral EVT over a period of more than 12 years, describe clinical and EVT characteristics, and immunotherapies applied.<h4>Methods</h4>A retrospective chart review of all patients treated by endovascular therapy for symptomatic or asymptomatic aneurysms at the University Hospital of Augsbu","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-04T19:54:40.619Z","creation":"2025-04-04T19:54:40.619Z"},"accession":"S-EPMC8808010","cross_references":{"pubmed":["35126670"],"doi":["10.1177/17562864211072372"]}}